Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease has been reported.
Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease.
AI Summary
Key Findings
Abstract
Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.
Affiliation
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. [email protected]
External References
- PubMed ID:
- 20056242
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.